KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Other Non-Current Assets (2018 - 2026)

Takeda Pharmaceutical has reported Other Non-Current Assets over the past 9 years, most recently at $491.1 million for Q1 2026.

  • For Q1 2026, Other Non-Current Assets rose 6.6% year-over-year to $491.1 million; the TTM value through Mar 2026 reached $491.1 million, up 6.6%, while the annual FY2026 figure was $511.6 million, 10.88% up from the prior year.
  • Other Non-Current Assets was $491.1 million for Q1 2026 at Takeda Pharmaceutical, up from $460.7 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $710.9 million in Q1 2022 and bottomed at $345.6 million in Q1 2024.
  • The 5-year median for Other Non-Current Assets is $478.7 million (2023), against an average of $497.4 million.
  • Year-over-year, Other Non-Current Assets crashed 32.65% in 2023 and then soared 33.3% in 2025.
  • Over 5 years, Other Non-Current Assets stood at $710.9 million in 2022, then plummeted by 32.65% to $478.7 million in 2023, then decreased by 27.81% to $345.6 million in 2024, then soared by 33.3% to $460.7 million in 2025, then rose by 6.6% to $491.1 million in 2026.
  • The last three reported values for Other Non-Current Assets were $491.1 million (Q1 2026), $460.7 million (Q1 2025), and $345.6 million (Q1 2024) per Business Quant data.